ID: ALA3589463

Max Phase: Preclinical

Molecular Formula: C29H26N4O9S

Molecular Weight: 606.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3nnnc3S(=O)(=O)c3ccc(C)cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O

Standard InChI:  InChI=1S/C29H26N4O9S/c1-14-4-6-16(7-5-14)43(36,37)29-30-31-32-33(29)26-18-11-21-20(41-13-42-21)10-17(18)24(25-19(26)12-40-28(25)35)15-8-22(38-2)27(34)23(9-15)39-3/h4-11,19,24-26,34H,12-13H2,1-3H3/t19-,24+,25-,26+/m0/s1

Standard InChI Key:  HTOJSUKPYAXFHO-QNMIOERPSA-N

Associated Targets(Human)

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-N-SH 1499 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tubulin 169 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 606.61Molecular Weight (Monoisotopic): 606.1420AlogP: 2.79#Rotatable Bonds: 6
Polar Surface Area: 161.19Molecular Species: NEUTRALHBA: 13HBD: 1
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.33CX Basic pKa: CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.32Np Likeness Score: 0.00

References

1. Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Sampath Kumar HM..  (2015)  Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds.,  25  (14): [PMID:26022842] [10.1016/j.bmcl.2015.04.053]

Source